UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033835
Receipt number R000038589
Scientific Title Clinical characteristics of papillary thyroid carcinoma patients with Delphian lymph node metastasis: a single-institution study, systemic review and meta-analysis
Date of disclosure of the study information 2018/08/21
Last modified on 2018/08/21 13:37:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical characteristics of papillary thyroid carcinoma patients with Delphian lymph node metastasis: a single-institution study, systemic review and meta-analysis

Acronym

Predicting spread to lymph nodes in papillary thyroid cancer patients based on clinical characteristics

Scientific Title

Clinical characteristics of papillary thyroid carcinoma patients with Delphian lymph node metastasis: a single-institution study, systemic review and meta-analysis

Scientific Title:Acronym

Predicting spread to lymph nodes in papillary thyroid cancer patients based on clinical characteristics

Region

Asia(except Japan)


Condition

Condition

thyroid carcinoma and Delphian lymph node metastasis

Classification by specialty

Endocrinology and Metabolism Endocrine surgery Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to evaluate the clinicopathological characteristics of papillary thyroid carcinoma patients with Delphian lymph node metastasis

Basic objectives2

Others

Basic objectives -Others

To identify the independent risk factors for Delphian lymph node metastasis and the ability of Delphian lymph node metastasis to predict further central lymph node metastasis and lateral lymph node metastasis

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Clinical characteristics of Delphian lymph node metastasis in thyroid carcinoma was evaluated from 2017 to 2018.

Key secondary outcomes

Independent risk factors for DLN metastasis, assessed through multivariate analysis of significant factors.
Ability of DLN metastasis to predict further central lymph node metastasis and lateral lymph node metastasis, assessed through reviewing central and lateral lymph node metastasis


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

1. Total thyroidectomy or ipsilateral thyroidectomy with central lymph node dissection
2. Aged 18-70
3. Preoperatively diagnosed with micropapillary carcinoma, based on ultrasound-guided fine needle aspiration cytology
4. Signed informed consent

Key exclusion criteria

1. Contraindications for anaesthesia (e.g. pregnancy, multiple organ failure, mental illness)
2. History of neck surgery or radiotherapy
3. Inability to comply with follow-up protocol

Target sample size

146


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ming Qiu

Organization

Changzheng Hospital affliated Second Military Medical University

Division name

Shanghai

Zip code


Address

No. 415 in Fengyang Road in Huangpu District

TEL

86-21-81885801

Email

qium127@smmu.edu.cn


Public contact

Name of contact person

1st name
Middle name
Last name Ming Qiu

Organization

Changzheng Hospital affliated Second Military Medical University

Division name

Shanghai

Zip code


Address

No. 415 in Fengyang Road in Huangpu District

TEL

86-21-81885801

Homepage URL


Email

qium127@smmu.edu.cn


Sponsor or person

Institute

Changzheng Hospital
General surgery department

Institute

Department

Personal name



Funding Source

Organization

the National Natural Science Foundation of China

Organization

Division

Category of Funding Organization

Outside Japan

Nationality of Funding Organization

China


Other related organizations

Co-sponsor

none

Name of secondary funder(s)

none


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Changzheng Hospital affliated Second Military Medical University


Other administrative information

Date of disclosure of the study information

2018 Year 08 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

In own series, Delphian lymph node metastasis was detected in 12 (8.2%) of 146 papillary thyroid carcinoma patients and was significantly associated with tumor size >1cm (P=0.029) and extrathyroid extension (P=0.002) in the multivariate analysis. Delphian lymph node metastasis was highly predictive of further central lymph node metastasis (positive predictive value=91.7%, netative predictive value=67.9%) and moderately predictive of lateral lymph node metastasis (positive predictive value=25.0%, negative predictive value=95.5%).

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2017 Year 06 Month 21 Day

Date of IRB


Anticipated trial start date

2017 Year 07 Month 01 Day

Last follow-up date

2018 Year 05 Month 31 Day

Date of closure to data entry

2018 Year 05 Month 31 Day

Date trial data considered complete

2018 Year 05 Month 31 Day

Date analysis concluded

2018 Year 06 Month 22 Day


Other

Other related information

none


Management information

Registered date

2018 Year 08 Month 21 Day

Last modified on

2018 Year 08 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038589


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name